Credit: Getty Images. Audenz is an inactivated cell-based influenza vaccine that contains MF59, a proprietary adjuvant. The Food and Drug Administration (FDA) has approved a multidose vial ...
EXCLUSIVE: SAB Biotherapeutics' Influenza Immunotherapy Shows Safety, Efficacy In Early-Stage Trials
SAB Biotherapeutics Inc SABS has announced the presentation of safety and efficacy data from Phase 1 and 2a trials of its influenza immunotherapy, SAB-176. It has recently received FDA Breakthrough ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback